

Bleeding at the back of the eye, also known as retinal haemorrhage, is a serious complication often associated with diabetic eye disease. It can result in vision loss and, if left untreated, may lead to blindness.
The condition is commonly linked to diabetic retinopathy, diabetic macular oedema (DMO), and diabetic maculopathy—three progressive eye diseases that affect individuals with diabetes. While traditional treatments such as laser therapy and eye injections exist, they come with side effects and are only offered once the disease has advanced.
The most common cause of retinal haemorrhage is diabetic retinopathy, a condition that affects people with diabetes. This happens because high blood sugar levels over time damage the tiny blood vessels in the retina, the part of the eye responsible for vision. Here’s how it works:
Several other factors can contribute to bleeding at the back of the eye, including:
Understanding these causes highlights the importance of proactive eye care, especially for individuals with diabetes who are at higher risk. Regular eye screenings, proper blood sugar control, and early intervention with treatments like Noctura 400 can significantly reduce the chances of severe retinal damage and vision loss.
In the NHS, traditional treatments for diabetic eye disease usually involve invasive procedures, such as laser surgery or intravitreal injections. These treatments only begin once doctors determine that the disease has significantly progressed. By this stage, damage has already occurred.
Noctura 400 offers an alternative: a comfortable, non-invasive treatment that helps manage diabetic eye disease early, preventing its progression.
If you have Diabetic Retinopathy or Diabetic Macular Oedema and you live in England, Wales, Scotland or Northern Ireland, you can check with your doctor to see if you are eligible for Noctura 400.
Unlike traditional NHS treatments, Noctura 400 does not require a waiting list, injections, or laser surgery. Instead, it provides a simple, at-home therapy that helps protect your eyesight from further deterioration.
Loss of sight doesn’t just affect vision; it impacts every aspect of life—your ability to work, drive, and literally see family and friends. Preventing diabetic eye disease from reaching an advanced stage is crucial. Noctura 400 is designed for those in the early stages of the condition or even before symptoms appear, ensuring that patients can take control of their eye health before invasive procedures become necessary.
Noctura 400 is a clinically tested, non-invasive therapy that supports retinal health by reducing the impact of diabetic-related damage. You can check with your doctor to see if you are eligible for Noctura 400, or alternatovely purchase it privately. It can be used alongside traditional NHS treatments.


